Press "Enter" to skip to content

Posts tagged as “VBLT”

VBL (VBLT) Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in OS and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer – StreetInsider.com

admin 0

VBL (VBLT) Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in OS and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer  StreetInsider.com VBL Therapeutics (Nasdaq: VBLT)…